학술논문
Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study
Document Type
article
Author
Source
Pediatric Rheumatology Online Journal, Vol 9, Iss Suppl 1, p O21 (2011)
Subject
Language
English
ISSN
1546-0096